710. In Vitro Activity and Performance of Available Susceptibility Testing Methods for Eravacycline Against Carbapenem-Resistant Enterobacteriaceae (CRE)

BACKGROUND: Eravacycline (ERV) is a recently-approved, fully synthetic fluorocycline agent that demonstrates broad in vitro activity against multidrug-resistant pathogens. We sought to compare the activity of ERV with minocycline (MIN) and tigecycline (TGC) against diverse CRE clinical isolates, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Chelsea E, Kline, Ellen G, Nguyen, Minh-Hong, Clancy, Cornelius J, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811212/
http://dx.doi.org/10.1093/ofid/ofz360.778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811212/
http://dx.doi.org/10.1093/ofid/ofz360.778

Ejemplares similares